UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM S-8

             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

                     MEDICAL TECHNOLOGY & INNOVATIONS, INC.
             ------------------------------------------------------
                 (Name of small business issuer in its charter)


         FLORIDA                                                65-2954561
- -----------------------------                        -------------------------
(State or other jurisdiction                           (I.R.S. Employer or
of incorporation organization)                               Identification No.)


3725 Investment Lane, Riviera Beach, FL                         33404
-----------------------------------------              ----------------------
(Address of principal place of business)                        (zip code)


                     Medical Technology & Innovations, Inc.
       Year 2000 Supplemental Employee/Consultant Stock Compensation Plan
             ------------------------------------------------------
                            (Full title of the plan)

                              Mintmire & Associates
                         265 Sunrise Avenue, Suite 204,
                              Palm Beach, FL 33480
                               Tel: (561) 832-5696
           -----------------------------------------------------------
            (Name, address and telephone number of agent for service)


                         CALCULATION OF REGISTRATION FEE

              PROPOSED       PROPOSED
 TITLE OF     AMOUNT         MAXIMUM     MAXIMUM
SECURITIES    OF SHARES      OFFERING    AGGREGATE     AMOUNT OF
TO BE         TO BE          PRICE       OFFERING      REGISTRATION
REGISTERED    REGISTERED     PER SHARE   PRICE         FEE (1)
------------  -------------  ----------  ----------    ------------
Common Stock  2,000,000 (2)   $0.11      $220,000      $58.08
No par



<PAGE>



(1)  Estimated  pursuant  to Rule  457(c) and 457(h)  solely for the  purpose of
calculating  the  Registration  Fee, which is based on the closing sale price of
the  Company's  Common Stock on the average of November 20, 21, 22, 24, 28, 2000
as reported on the OTC Electronic Bulletin Board.

(2)  Represents  the  maximum  number of shares  which may be granted  under the
Medical    Technology   &    Innovations,    Inc.    Year   2000    Supplemental
Employee/Consultant Stock Compensation Plan (the "Plan").


                                     PART II

                 INFORMATION REQUIRED IN REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference

     The  following   documents  which  have  been  heretofore  filed  with  the
Securities and Exchange Commission (the "Commission") by the Registrant pursuant
to the Securities  Exchange Act of 1934 (the "Exchange Act") are incorporated by
reference in this Registration Statement:

         (1)     The  Registrant's  Annual  Report on Form l0-KSB for the fiscal
year ended June 30, 2000;

         (2) All  other  reports  filed by the  Registrant  with the  Commission
pursuant to Section  13(a) or Section 15(d) of the Exchange Act since the end of
the fiscal year covered by the Registrant's Annual Report referred to above; and

         (3)     The description of the Common Stock of the Registrant contained
in the Registrant's Registration Statement.

         All documents filed by the Registrant  with the Commission  pursuant to
Section 13(a),  13(c), 14 or 15(d) of the Exchange Act subsequent to the date of
this  Registration  Statement  and  prior  to  the  filing  of a  post-effective
amendment  hereto which indicates that all securities  offered have been sold or
which  deregisters all securities then remaining  unsold,  shall be deemed to be
incorporated by reference herein and to be a part hereof from the date of filing
of such documents.

Item 4. Description of Securities.

         Not applicable.

Item 5. Interests of Named Experts and Counsel.

         Not applicable.

Item 6. Indemnification of Directors and Officers.

     The Bylaws of the  Registrant  contain  provisions  which  provide  for the
indemnification  of directors,  officers,  and other  employees or agents of the
Registrant properly appointed to serve


<PAGE>



in an official capacity who while acting in good faith, in the best interests of
the Registrant,  and within the scope of their offices, are or are threatened to
be named as a defendant or respondent in a civil or criminal action.  The extent
of the indemnification is limited to judgements,  penalties,  fines, settlements
and reasonable expenses actually incurred.

Item 7. Exemption from Registration Claimed.

         Not applicable.

Item 8.   Exhibits.

*          5.2 Opinion of Mintmire & Associates

*         10.2 Medical Technology & Innovations, Inc. Year 2000 Supplemental
               Employee/Consultant Stock Compensation Plan

*         23.2 Consent of Simon Lever & Company

          23.3 Consent of Mintmire & Associates  (contained in the opinion
               filed as Exhibit 5.2 hereof)
----------------------------
(* filed herewith)

Item 9. Undertakings.

The Registrant hereby undertakes:

(a) (1) to file,  during  any period in which it offers or sells  securities,  a
post  effective  amendment  to  this  registration   statement  to  include  any
prospectus required by Section 10(a) (3) of the Securities Act;

         (2) that,  for the  purpose  of  determining  any  liability  under the
Securities  Act  of  1933,  to  treat  each  post-effective  amendment  as a new
registration  statement  of the  securities  offered,  and the  offering  of the
securities at that time to be the initial bona fide offering;

         (3) to remove from registration by means of a post-effective  amendment
any of the securities that remain unsold at the end of the offering.

         Insofar as indemnification for liabilities arising under the Securities
Act of 1933 (the "Act") may be permitted to directors, officers, and controlling
persons of the small business  issuer pursuant to the foregoing  provisions,  or
otherwise, the small business issuer has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy
as expressed in the Act and is,  therefore,  unenforceable.  In the event that a
claim for  indemnification  against such liabilities  (other than the payment by
the Company in the  successful  defense of any action,  suit or  proceeding)  is
asserted by such director,  officer or controlling person in connection with the
securities  being  registered,  the Company will,  unless in the opinion of this
counsel that matter has been settled by controlling precedent, submit to a court
of appropriate  jurisdiction the question whether such  indemnification by it is
against  public policy as expressed in the Act and will be governed by the final
jurisdiction of such issue.


<PAGE>






                                   SIGNATURES

Pursuant to the  requirements  of the  Securities  Act of 1933,  the  registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-8 and has  duly  caused  this  Registration
Statement to be signed on its behalf, in the City of Riviera Beach,  Florida, on
November 27, 2000.

                                      MEDICAL TECHNOLOGY & INNOVATIONS, INC.

                                      By:     /s/ Jeremy Feakins
                                          ---------------------------
                                               Jeremy Feakins
                                               CEO

Pursuant to the  requirements of the Securities Act of 1933,  this  registration
statement has been signed by the following  persons in the capacities and on the
dates indicated.


   Signature                        Title                        Date
-------------------------      -------------------        -------------------


/s/ Jeremy Feakins
-------------------------      CEO, Director              November 27, 2000
Jeremy Feakins

/s/ Joseph DelVecchio
-------------------------      Executive Vice Pres.       November 28, 2000
Joseph DelVecchio              COO, Director

/s/ Albert Dugan
-------------------------      Secretary                  November 28, 2000
Albert Dugan

/s/ Dennis Surovcik
-------------------------                                 November 27, 2000
Dennis Surovcik                Director
[{"type": "S-8", "sequence": "1", "filename": "0001.txt", "description": "1933 REGISTRATION STATEMENT", "secsgml_size_bytes": 8647}]
{"company-data": {"conformed-name": "MEDICAL TECHNOLOGY & INNOVATIONS INC /FL/", "cik": "0000847464", "assigned-sic": "7900", "irs-number": "652954561", "state-of-incorporation": "FL", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-50888", "film-number": "780198"}, "business-address": {"street1": "615 CENTERVILLE ROAD", "city": "LANCASTER", "state": "PA", "zip": "17601", "phone": "7178926770"}, "mail-address": {"street1": "615 CENTERVILLE ROAD", "city": "LANCASTER", "state": "PA", "zip": "17601"}}
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM S-8

             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

                     MEDICAL TECHNOLOGY & INNOVATIONS, INC.
             ------------------------------------------------------
                 (Name of small business issuer in its charter)

         FLORIDA                                                65-2954561
- -----------------------------                        -------------------------
(State or other jurisdiction                           (I.R.S. Employer or
of incorporation organization)                               Identification No.)

3725 Investment Lane, Riviera Beach, FL                         33404
-----------------------------------------              ----------------------
(Address of principal place of business)                        (zip code)

                     Medical Technology & Innovations, Inc.
       Year 2000 Supplemental Employee/Consultant Stock Compensation Plan
             ------------------------------------------------------
                            (Full title of the plan)

                              Mintmire & Associates
                         265 Sunrise Avenue, Suite 204,
                              Palm Beach, FL 33480
                               Tel: (561) 832-5696
           -----------------------------------------------------------
            (Name, address and telephone number of agent for service)

                         CALCULATION OF REGISTRATION FEE

              PROPOSED       PROPOSED
 TITLE OF     AMOUNT         MAXIMUM     MAXIMUM
SECURITIES    OF SHARES      OFFERING    AGGREGATE     AMOUNT OF
TO BE         TO BE          PRICE       OFFERING      REGISTRATION
REGISTERED    REGISTERED     PER SHARE   PRICE         FEE (1)
------------  -------------  ----------  ----------    ------------
Common Stock  2,000,000 (2)   $0.11      $220,000      $58.08
No par
(1)  Estimated  pursuant  to Rule  457(c) and 457(h)  solely for the  purpose of
calculating  the  Registration  Fee, which is based on the closing sale price of
the  Company's  Common Stock on the average of November 20, 21, 22, 24, 28, 2000
as reported on the OTC Electronic Bulletin Board.

(2)  Represents  the  maximum  number of shares  which may be granted  under the
Medical    Technology   &    Innovations,    Inc.    Year   2000    Supplemental
Employee/Consultant Stock Compensation Plan (the "Plan").

                                     PART II

                 INFORMATION REQUIRED IN REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference

     The  following   documents  which  have  been  heretofore  filed  with  the
Securities and Exchange Commission (the "Commission") by the Registrant pursuant
to the Securities  Exchange Act of 1934 (the "Exchange Act") are incorporated by
reference in this Registration Statement:

         (1)     The  Registrant's  Annual  Report on Form l0-KSB for the fiscal
year ended June 30, 2000;

         (2) All  other  reports  filed by the  Registrant  with the  Commission
pursuant to Section  13(a) or Section 15(d) of the Exchange Act since the end of
the fiscal year covered by the Registrant's Annual Report referred to above; and

         (3)     The description of the Common Stock of the Registrant contained
in the Registrant's Registration Statement.

         All documents filed by the Registrant  with the Commission  pursuant to
Section 13(a),  13(c), 14 or 15(d) of the Exchange Act subsequent to the date of
this  Registration  Statement  and  prior  to  the  filing  of a  post-effective
amendment  hereto which indicates that all securities  offered have been sold or
which  deregisters all securities then remaining  unsold,  shall be deemed to be
incorporated by reference herein and to be a part hereof from the date of filing
of such documents.

Item 4. Description of Securities.

         Not applicable.

Item 5. Interests of Named Experts and Counsel.

         Not applicable.

Item 6. Indemnification of Directors and Officers.

     The Bylaws of the  Registrant  contain  provisions  which  provide  for the
indemnification  of directors,  officers,  and other  employees or agents of the
Registrant properly appointed to serve
in an official capacity who while acting in good faith, in the best interests of
the Registrant,  and within the scope of their offices, are or are threatened to
be named as a defendant or respondent in a civil or criminal action.  The extent
of the indemnification is limited to judgements,  penalties,  fines, settlements
and reasonable expenses actually incurred.

Item 7. Exemption from Registration Claimed.

         Not applicable.

Item 8.   Exhibits.

*          5.2 Opinion of Mintmire & Associates

*         10.2 Medical Technology & Innovations, Inc. Year 2000 Supplemental
               Employee/Consultant Stock Compensation Plan

*         23.2 Consent of Simon Lever & Company

          23.3 Consent of Mintmire & Associates  (contained in the opinion
               filed as Exhibit 5.2 hereof)
----------------------------
(* filed herewith)

Item 9. Undertakings.

The Registrant hereby undertakes:

(a) (1) to file,  during  any period in which it offers or sells  securities,  a
post  effective  amendment  to  this  registration   statement  to  include  any
prospectus required by Section 10(a) (3) of the Securities Act;

         (2) that,  for the  purpose  of  determining  any  liability  under the
Securities  Act  of  1933,  to  treat  each  post-effective  amendment  as a new
registration  statement  of the  securities  offered,  and the  offering  of the
securities at that time to be the initial bona fide offering;

         (3) to remove from registration by means of a post-effective  amendment
any of the securities that remain unsold at the end of the offering.

         Insofar as indemnification for liabilities arising under the Securities
Act of 1933 (the "Act") may be permitted to directors, officers, and controlling
persons of the small business  issuer pursuant to the foregoing  provisions,  or
otherwise, the small business issuer has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy
as expressed in the Act and is,  therefore,  unenforceable.  In the event that a
claim for  indemnification  against such liabilities  (other than the payment by
the Company in the  successful  defense of any action,  suit or  proceeding)  is
asserted by such director,  officer or controlling person in connection with the
securities  being  registered,  the Company will,  unless in the opinion of this
counsel that matter has been settled by controlling precedent, submit to a court
of appropriate  jurisdiction the question whether such  indemnification by it is
against  public policy as expressed in the Act and will be governed by the final
jurisdiction of such issue.
SIGNATURES

Pursuant to the  requirements  of the  Securities  Act of 1933,  the  registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-8 and has  duly  caused  this  Registration
Statement to be signed on its behalf, in the City of Riviera Beach,  Florida, on
November 27, 2000.

                                      MEDICAL TECHNOLOGY & INNOVATIONS, INC.

                                      By:     /s/ Jeremy Feakins
                                          ---------------------------
                                               Jeremy Feakins
                                               CEO

Pursuant to the  requirements of the Securities Act of 1933,  this  registration
statement has been signed by the following  persons in the capacities and on the
dates indicated.

   Signature                        Title                        Date
-------------------------      -------------------        -------------------

/s/ Jeremy Feakins
-------------------------      CEO, Director              November 27, 2000
Jeremy Feakins

/s/ Joseph DelVecchio
-------------------------      Executive Vice Pres.       November 28, 2000
Joseph DelVecchio              COO, Director

/s/ Albert Dugan
-------------------------      Secretary                  November 28, 2000
Albert Dugan

/s/ Dennis Surovcik
-------------------------                                 November 27, 2000
Dennis Surovcik                Director